TXNIP and diabetic kidney disease: Recently, Shah et al. have reported confirmatory findings that diabetic TXNIP−/− mice are resistant to diabetes nephropathy, with preserved renal function, reduced tubulointerstitial fibrosis, expression of TGF-β1, type IV collagen, oxidative stress and inflammation compared to the diabetic TXNIP+/+ mice7.